Ironwood Pharmaceuticals Stock News

Ironwood Pharmaceuticals (NASDAQ:IRWD) is scheduled to announce Q4 earnings results on Thursday, February 17th, before market open.The consensus EPS Estimate is $0.34 (-5.6% Y/Y) and…

Let us take a look at four biotech or drug companies - RGEN, IRWD, EXEL and LGND - due to release their quarterly results on Feb 16.

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate

Is Ironwood Pharmaceuticals (IRWD) a great pick from the value investor's perspective right now? Read on to know more.

Is Ironwood Pharmaceuticals (IRWD) a great pick from the value investor's perspective right now? Read on to know more.

Gainers: Puma Biotechnology PBYI +16%, Marin Software (MRIN) +9%, Midland States Bancorp (MSBI) +6%, IDEAYA Biosciences (IDYA) +3%, Ironwood Pharmaceuticals (IRWD) +3%.Losers:…

Ironwood Pharmaceuticals <> sees FY21 LINZESS U.S. net sales to exceed $1B with LINZESS U.S. net sales growth, total Ironwood revenues, and Ironwood adjusted EBITDA to be at the…

Investors are keenly aware that growth stocks have beaten value stocks five years in a row. So what am I going to recommend today?

Related Stocks: IRWD ,

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) COO Jason Rickard sold 27,000 shares of Ironwood Pharmaceuticals stock in a transaction that occurred on Thursday, December 16th. The shares were sold at an average price of $11.28, for a total transaction of $304,560.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is […]

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) COO Jason Rickard sold 27,000 shares of the business’s stock in a transaction dated Thursday, December 16th. The stock was sold at an average price of $11.28, for a total transaction of $304,560.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Jason […]

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Julie Mchugh sold 10,000 shares of Ironwood Pharmaceuticals stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $11.02, for a total value of $110,200.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed []

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Julie Mchugh sold 10,000 shares of Ironwood Pharmaceuticals stock in a transaction that occurred on Tuesday, December 14th. The shares were sold at an average price of $11.02, for a total transaction of $110,200.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is []

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Julie Mchugh sold 10,000 shares of the companys stock in a transaction that occurred on Tuesday, December 14th. The shares were sold at an average price of $11.02, for a total value of $110,200.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the []